Does vaginal hysterectomy have an interest for large uterus of more than 500 g? (Comparison with laparotomy);L'hysterectomie vaginale a-t-elle un interet pour les gros uterus de plus de 500 g?: Comparaison avec la laparotomie

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 27, Issue 6, 1998, Pages 585-592

  Switala, I ^a   Cosson, M ^a,c   Lanvin, D ^a   Querleu, D ^b   Crepin, G ^b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Paul Gelle Hospital   (France)

Author keywords

Hysterectomy; Vaginal hysterectomy

Indexed keywords

ANALGESIC AGENT; HEMOGLOBIN;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTROPHY; INTERMETHOD COMPARISON; LAPAROTOMY; POSTOPERATIVE COMPLICATION; SURGICAL APPROACH; UTERUS; UTERUS WEIGHT; VAGINAL HYSTERECTOMY; COMPARATIVE STUDY; HYSTERECTOMY; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PEROPERATIVE COMPLICATION; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; HYSTERECTOMY, VAGINAL; INTRAOPERATIVE COMPLICATIONS; LAPAROTOMY; MIDDLE AGED; ORGAN SIZE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; UTERUS;

EID: 0031732289     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cosson M, Querleu D, Subtil D et al. The leasability of vaginal hysterectomy. Eur J Obstet Gynecol 1996;64:95-9.
2. Casey MJ, Garcia-Padal J, Johnson C, Osborne NG, Sotolongo J, Watson P. A critical analysis of laparoscopic assisted vaginal hysterectomies compared with vaginal hysterectomies unassisted by laparoscopy and transabdominal hysterectomies. J Gynecol Surg 1994;10:7-14.
3. Dargent D, Rudigoz RD. L'hystérectomie vaginale: notre expérience des années 1970 à 1979 (556 opérations). J Gynecol. Obstet Biol Reprod 1980;2895-908.
4. Kovac SR, Christie SG, Bindbeutel GA. Abdominal versus vaginal hysterectomy: a statical model for determining physician decision making and patient outcome. Med Decis Making 1991;11:19-28.
5. Dicker RC, Greenspan JR, Strauss LT et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States: the collaborative review of sterilisation. Am J Obstet Gynecol 1982;144:841-8.
6. Kovac SR. Guideline to determine the route of hysterectomy. Obstet Gynecol 1995;85:18-23.
7. Cosson M. L'hystérectomie. Passé, présent, avenir. Thèse pour le Doctorat en Médecine, Lille, 1993.
8. Fernandez H. La fin de l'hystérectomie par voie abdominale? Intérêt de la coeliochirurgie. La Lettre du Gynécologue 1992;161:3.
9. Switala I. L'hystérectomie vaginale a t-elle un intéret pour les gros utérus? Thèse pour le doctorat en Médecine, Lille, 1995.
10. Hoffman MS, De Cesare S, Kalter C. Abdominal hysterectomy versus transvaginal morcellation for the removal of enlarged uteri. Am J Obstet Gynecol 1994;171:309-15.
11. Precis IV. An update in obstetrics and gynecology. Washington, DC: American College of Obstetricians and Gynecologists, 1990:197.
12. Mazdisnian F, Kurzel RB, Coe S, Bozuk M, Montz F. Vaginal hysterectomy by uterine morcellation: an efficient, nonmorbid procedure. Obstet Gynecol 1995;86:60-64.
13. Grody MHT. Vaginal hysterectomy: the large uterus. J Gynecol Surg 1989;5:301-12.
14. Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W et al. An evaluation, of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-contrlled, cross over trial. J Clin Endocrinol Metab 1993;76:1217-23.
15. Friedman AJ, Hoffman DI, Comite F, Browneller R.W, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The leuprolide study group. Obstet Gynecol 1991;77:720-5.
16. Golan A, Bukovsky I, Schneider D, Ron-El R, Herman A, Caspi E. D. Trp6 luteinizing releasing hormone (microcapsules) treatment of uterine leiomyomata. Fertil Steril 1989;52:406-11.
17. Schneider D, Golan A, Bukowsky I, Pansky M, Caspi E. GnRh analogue-induced uterine shrintage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri. Obstet Gynecol 1991;78:540-1.
18. Stovall TG. Gonadotropin-releasing hormone agonistys: utilization before hysterectomy. Clin Obstet Gynecol 1993;36: 642-9.
19. Stovall TG, Ling FW, Henry LC, Woodruff MR. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas Am J Obstet Gynecol 1991;164:1420-5.
20. Verkauf BS. Changing trends in treatment of leiomyomata uteri. Curr Opinion Obstet Gynecol 1993;5:301-10.
21. West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with gosereline (Zoladex): luteinizing releasing hormone agonist administred as a monthly subcutaneous depot. Fertil Steril 1987;48:45-51.
22. Cosson M, Querleu D, Elhage A, Delest A, Crepin G. Coûts respectif et complications des voies d'abord des hystérectomies. Jobgyn 1994;2:415-24.